Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vascular Surgery

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 16 articles: HTML format Text format

Single Articles

October 2018
1. SORRENTINO S, Baber U, Claessen BE, Camaj A, et al
   Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention.
   Thromb Haemost. 2018 Oct 12. doi: 10.1055/s-0038-1673687.
   PubMed     Text format     Abstract available
   
   
   August 2018
2. KARHAUSEN JA, Qi W, Smeltz AM, Li YJ, et al
   Genome-Wide Association Study Links Receptor Tyrosine Kinase Inhibitor Sprouty 2 to Thrombocytopenia after Coronary Artery Bypass Surgery.
   Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1667199.
   PubMed     Text format     Abstract available
   
   
   
3. GROSS L, Trenk D, Jacobshagen C, Krieg A, et al
   Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping Substudy.
   Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1667337.
   PubMed     Text format     Abstract available
   
   
   July 2017
4. HARADA Y, Michel J, Lohaus R, Mayer K, et al
   Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents.
   Thromb Haemost. 2017;117.
   PubMed     Text format     Abstract available
   
   
   
5. SILLER-MATULA J, Lang IM, Schoergenhofer C, Roest M, et al
   Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.
   Thromb Haemost. 2017;117.
   PubMed     Text format     Abstract available
   
   
   June 2017
6. CUBEDO J, Blasco A, Padro T, Ramaiola I, et al
   Molecular signature of coronary stent thrombosis: oxidative stress and innate immunity cells.
   Thromb Haemost. 2017;117.
   PubMed     Text format     Abstract available
   
   
   May 2017
7. SEREBRUANY VL, Kim MH, Cabrera-Fuentes HA, Lee K, et al
   Mortality and cancer after 12 versus 30 months dual antiplatelet therapy. The Korean Outcomes Registry Evaluating Antithrombotics (KOREA).
   Thromb Haemost. 2017;117:934-939.
   PubMed     Text format     Abstract available
   
   
   March 2017
8. CAMPO G, Vieceli Dalla Sega F, Pavasini R, Aquila G, et al
   Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease.
   Thromb Haemost. 2017 Mar 23. doi: 10.1160/TH16-12-0973.
   PubMed     Text format     Abstract available
   
   
   February 2017
9. CHRISTOPOULOS C, Farag M, Sullivan K, Wellsted D, et al
   Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention.
   Thromb Haemost. 2017;117:457-470.
   PubMed     Text format     Abstract available
   
   
   
10. BIANCARI F, Brascia D, Onorati F, Reichart D, et al
    Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score.
    Thromb Haemost. 2017;117:445-456.
    PubMed     Text format     Abstract available
    
    
    
11. URBANSKI K, Ludew D, Filip G, Filip M, et al
    CD14+CD16++ "nonclassical" monocytes are associated with endothelial dysfunction in patients with coronary artery disease.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-08-0614.
    PubMed     Text format     Abstract available
    
    
    
12. FREYNHOFER MK, Iliev L, Bruno V, Rohla M, et al
    Platelet turnover predicts outcome after coronary intervention.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-10-0785.
    PubMed     Text format     Abstract available
    
    
    
13. PARK Y, Tantry US, Koh JS, Ahn JH, et al
    Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
    Thromb Haemost. 2017 Feb 2. doi: 10.1160/TH16-10-0744.
    PubMed     Text format     Abstract available
    
    
    October 2016
14. FLIERL U, Zauner F, Sieweke JT, Berliner C, et al
    Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction.
    Thromb Haemost. 2016;117.
    PubMed     Text format     Abstract available
    
    
    September 2016
15. SIBBING D, Aradi D, Jacobshagen C, Gross L, et al
    A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on chronic Antiplatelet Treatment for Acute Coronary Syndr
    Thromb Haemost. 2016;117.
    PubMed     Text format     Abstract available
    
    
    June 2016
16. MEESTERS MI, Veerhoek D, de Lange F, de Vries JW, et al
    Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: